Key Takeaways
- • First Block, Onpharma Company, and Crito Capital launched what is believed to be the first Solana-based Security Token Offering (STO) for an established U.S. operating business, marking a structural shift in private markets tokenization on June 17, 2026.
- • Onpharma's STO tokenizes equity ownership in a U.S. medical device company focused on dentistry, structured as a Regulation S offshore issuance to non-U.S. qualified investors, with the offering available at sto.onpharma.com.
- • The Solana-based framework enables atomic settlement, programmable ownership architecture, and cross-border distribution with near-instantaneous secondary trading liquidity and low transaction costs compared to traditional private market infrastructure.
- • Onpharma's platform offers recurring revenue and high gross margins within a significant dental device market opportunity, providing investors with exposure to an established operating business rather than pre-revenue ventures.
- • The tokenized structure eliminates fragmented multi-intermediary processes inherent to traditional private markets, enabling issuance, settlement, and secondary trading on-chain across compatible wallets subject to KYC controls under applicable securities frameworks.
Summary
First Block, Inc., a digital securities and tokenization infrastructure provider, announced the launch of the first Solana-based Security Token Offering for an established U.S. operating business in partnership with Onpharma Company and UK-based Crito Capital LLP. The transaction represents a structural milestone in modernizing global private markets by deploying blockchain-based capital formation for real-world operating companies rather than speculative or pre-revenue ventures.
Onpharma's dental medical device platform generates recurring revenue and maintains high gross margins, providing qualified investors with direct exposure to an operational business with proven market traction. The STO structure converts ownership rights in the company's common stock into blockchain-based digital tokens, facilitating rapid issuance and settlement while maintaining compliance with U.S. securities law. The offering is structured as a Regulation S offshore issuance to non-U.S. qualified investors, with secondary trading capabilities on-chain.
The Solana blockchain infrastructure underlying the offering combines atomic settlement technology with programmable ownership architecture and digital distribution capabilities. This framework eliminates the fragmented, multi-intermediary processes that have historically constrained private market efficiency. Investors gain access to near-instantaneous settlement for secondary transactions, trading liquidity across compatible wallets, and international accessibility under applicable securities frameworks such as Regulation S, all at significantly lower costs than traditional private market infrastructure.
The tokenized structure enables qualified international investors to access validated, revenue-generating private companies through a modernized capital formation process. Secondary transactions settle on-chain subject to KYC controls, providing transparent ownership transfer and enhanced liquidity for participants in what has traditionally been an illiquid market segment. This transaction signals growing institutional acceptance of blockchain-based securities settlement for real operating companies in regulated markets.
Onpharma's dental medical device platform generates recurring revenue and maintains high gross margins, providing qualified investors with direct exposure to an operational business with proven market traction. The STO structure converts ownership rights in the company's common stock into blockchain-based digital tokens, facilitating rapid issuance and settlement while maintaining compliance with U.S. securities law. The offering is structured as a Regulation S offshore issuance to non-U.S. qualified investors, with secondary trading capabilities on-chain.
The Solana blockchain infrastructure underlying the offering combines atomic settlement technology with programmable ownership architecture and digital distribution capabilities. This framework eliminates the fragmented, multi-intermediary processes that have historically constrained private market efficiency. Investors gain access to near-instantaneous settlement for secondary transactions, trading liquidity across compatible wallets, and international accessibility under applicable securities frameworks such as Regulation S, all at significantly lower costs than traditional private market infrastructure.
The tokenized structure enables qualified international investors to access validated, revenue-generating private companies through a modernized capital formation process. Secondary transactions settle on-chain subject to KYC controls, providing transparent ownership transfer and enhanced liquidity for participants in what has traditionally been an illiquid market segment. This transaction signals growing institutional acceptance of blockchain-based securities settlement for real operating companies in regulated markets.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.